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Supplementary Figure 1: Design of the retroviral vectors used in this study and transduction efficiencies of primary 
murine T and B cells. (A) The cDNA of the human BATF3 gene was cloned into the gammaretroviral vector MP91-EGFP [1]. Sequences 
of BLIMP1-specific shRNAs and a non-specific scrambled control-shRNA were cloned into the lentiviral vector LeGO-Cer [2]. Targeted 
BLIMP1-sequences of shRNA1 and shRNA2 depicted in brackets. RV, gammaretroviral vector; LV, lentiviral vector; EGFP, enhanced 
green fluorescent protein; LTR, long terminal repeat; SIN-LTR, self-inactivating long terminal repeat; IRES, internal ribosomal entry 
site; RRE, Rev response element; cPPT, central polypurine tract; SFFV, spleen focus-forming virus; wPRE, woodchuck hepatitis virus 
posttranscriptional regulatory element. (B) Gene marking of transplanted mature T and B cells after retroviral transduction with RV-Batf3 
or control-gene encoding vector RV-EGFP. For B cells a highly BATF3-transduced and a low BATF3-transduced transplant was prepared.
Supplementary Figure 2: BATF3 expression induced oligoclonal B-cell tumors. (A) Western blot of several BATF3-induced 
murine lymphomas demonstrated variable BATF3-expression levels. In vivo expanded and sorted B cells from the EGFP-control cohort 
served as negative control. (B) Retroviral integration analyses of BATF3-induced tumor material via LM-PCR. Every band represents a 
different integration site in the mouse genome. IC, internal control from vector sequence.
Supplementary Figure 3: Targeted knockdown of BLIMP1 in multiple myeloma cell lines MOLP8 and L363. Multiple 
myeloma cell lines L363 (A) and MOLP8 (B) were either transduced with two different BLIMP1-targeting shRNAs (BLIMP1shRNA1 and 
BLIMP1shRNA2) or a non-specific, scrambled shRNA as control (Controlscr-shRNA). After two weeks of culture, BLIMP1-specific knockdown 
with shRNA1 resulted in a dramatically impaired cell expansion of reporter gene expressing cells in both cell lines. Data from three 
independent experiments are shown. Error bars represent standard deviation. Statistical significance was established with a paired t test. **, 
P < 0.01, ***, P < 0.0001
Supplementary Table 1: Phenotype of transplanted cells
Group CD19/B220 
double positive
GL7/Fas double 
positive
CXCR4 CXCR5 IgM IgD IgG Igλ Igκ CD86 CD83
RV-
EGFP
99.2 99.8 21.0 82.2 88.9 74.3 10.2 17.6 81.0 97.5 52.0
RV-
BATF3
98.7 98.9 18.9 80.1 92.8 72.1 11.8 21.1 75.4 96.1 57.7
Supplementary Table 2: Primers for amplification of the coding sequence of BATF3
Primer Sequence 5′ → 3′
EX1 FW1 TGC GGC ACG AGG ATG CC
EX1 FW2 TAG GCA GCC CCA CGG GC
EX1 RV1 CTG GAG TTC CGT GGT GGT GA
EX1 RV2 GGA GAC AAG CAG AGG TAG GG
EX2 FW1 GGT GCT GTC TAC TGC AAA GC
EX2 FW2 AGA AAA GGG TAA GGC GAG G
EX2 RV1 CTA ATT TCT GCC AGG TCC TTC C
EX2 RV2 CTG AGT GCT TCT CAT GGT CA
EX3 FW1 GCT TTC ATG GGC AAG AGG TG
EX3 FW2 GAG GAA GGG AAC GCT GC
EX3 RV1 CTC AGC CCG ACA TCC AAC A
EX3 RV2 AGA TCC AGC ATG GAG GCC A
EX, exon; FW, forward primer; RV, reverse primer.
